Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marzieh Bahador"'
Autor:
Terje Sundstrøm, Lars Prestegarden, Francisco Azuaje, Synnøve Nymark Aasen, Gro Vatne Røsland, Jobin K. Varughese, Marzieh Bahador, Simon Bernatz, Yannick Braun, Patrick N. Harter, Kai Ove Skaftnesmo, Elizabeth S. Ingham, Lisa M. Mahakian, Sarah Tam, Clifford G. Tepper, Kjell Petersen, Katherine W. Ferrara, Karl Johan Tronstad, Morten Lund-Johansen, Rudi Beschorner, Rolf Bjerkvig, Frits Thorsen
Publikováno v:
Acta Neuropathologica Communications, Vol 7, Iss 1, Pp 1-19 (2019)
Abstract Melanoma patients carry a high risk of developing brain metastases, and improvements in survival are still measured in weeks or months. Durable disease control within the brain is impeded by poor drug penetration across the blood-brain barri
Externí odkaz:
https://doaj.org/article/a1c9daff0c9545dea71bc7623876a310
Autor:
Wenjing Zhou, Elena Martinez-Garcia, Katharina Sarnow, Georgia Kanli, Petr Nazarov, Stephanie G. Schwab, Johannes Meiser, Christian Jäger, Jakub Mieczkowski, Frits A. Thorsen, Konrad Grützmann, Boris Mihaljevic, Barbara van Loon, Jubayer A. Hossain, Anna Golebiewska, Simone Niclou, Magnar Bjørås, Saverio Tardito, Justin Vareecal Joesph, Taral R. Lunavat, Halala Sdik Saed, Marzieh Bahador, Minghzi Han, Carina Fabian, Hrvoje Miletic, Xingang Li, Jian Wang, Gunnar Dittmar, Olivier Keunen, Barbara Klink, Rolf Bjerkvig
Publikováno v:
SSRN Electronic Journal.
Autor:
Justin V. Joseph, Heidi Espedal, Martha Chekenya, Laura Trachsel-Moncho, Mohummad Aminur Rahman, Einar K. Kristoffersen, Andrea Gras Navarro, Anne Simonsen, Per Øyvind Enger, Marzieh Bahador, Hrvoje Miletic, Bjørn Tore Gjertsen
Publikováno v:
Cancers
Volume 11
Issue 7
Cancers, Vol 11, Iss 7, p 996 (2019)
Volume 11
Issue 7
Cancers, Vol 11, Iss 7, p 996 (2019)
Background: Natural killer (NK) cells are potential effectors in anti-cancer immunotherapy
however only a subset potently kills cancer cells. Here, we examined whether pretreatment of glioblastoma (GBM) with the proteasome inhibitor, bortezomib
however only a subset potently kills cancer cells. Here, we examined whether pretreatment of glioblastoma (GBM) with the proteasome inhibitor, bortezomib
Autor:
J V Joesph, Jian Wang, Barbara Klink, Mingzhi Han, Marzieh Bahador, Rolf Bjerkvig, Taral R. Lunavat, Wenjing Zhou, Hrvoje Miletic
BACKGROUND: We have previously developed a brain organoid system based on the development of fetal rat brain cells taken from fetuses at the 18th day of gestation. The purpose of the present work was to use the latest technologies to assess in detail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5070530af6c17d99e42d59262509c286
https://europepmc.org/articles/PMC6144704/
https://europepmc.org/articles/PMC6144704/
Autor:
J V Joesph, Barbara Klink, E M Garcia, Taral R. Lunavat, Wenjing Zhou, Mingzhi Han, Rolf Bjerkvig, Jian Wang, Marzieh Bahador, Petr V. Nazarov, Gunnar Dittmar, H S Saed
Publikováno v:
Europe PubMed Central
Neuro Oncol
Neuro Oncol
BACKGROUND Glioblastoma (GBM) cell infiltration into the surrounding normal brain tissue where the blood brain barrier is intact, represents a major problem for clinical management and therapy. There is a vital need to understand the molecular mechan
Autor:
Martha Chekenya, Anne Simonsen, Dorota Goplen, Agnete S.T. Engelsen, Bjørn Tore Gjertsen, Per Øyvind Enger, Jorunn Brekke, Marzieh Bahador, Mohummad Aminur Rahman, Shahin Sarowar, Christian Bindesbøll, Andrea Gras Navarro, Frode Selheim
Publikováno v:
Cancer Research. 78:2928-2928
Background: Glioblastoma with unmethylated O6-methyl guanine DNA methyltransferase (MGMT) promoter is highly resistant to temozolomide (TMZ) chemotherapy. Strategies that ameliorate drug resistance are sorely needed. Recent trials of the proteasome i
Publikováno v:
Cancer Research. 77:LB-195
Introduction: Glioblastoma (GBM) is the most aggressive and lethal brain cancer in adults where best available therapy combining surgery and concomitant chemo radiation prolongs patient survival from 12.1 to 14.6 months. Approximately half of the pat
Autor:
M Dominguez-Valentin, Mohummad Aminur Rahman, Gro Njølstad, Shahin Sarowar, Eirik Bratland, A Gras Navarro, Martha Chekenya, Elling Ulvestad, Stein Atle Lie, Einar K. Kristoffersen, Marzieh Bahador
Publikováno v:
OncoImmunology, Vol 6, Iss 8 (2017)
Oncoimmunology
Oncoimmunology
Human cytomegalovirus (HCMV) antigens in glioblastoma (GBM) present opportunities for personalised immunotherapy. However, their presence in GBM tissue is still under debate, and evidence of their impact on functional immune responses and prognosis i
Publikováno v:
Zīst/shināsī-i Giyāhī-i Īrān, Vol 7, Iss 24, Pp 1-14 (2015)
Salsola richteri (chenopodiaceae) has been dispersed in desert areas of north and east of the Irano-Turanian region in Iran. In present study, physiological characteristics of S. richteri to drought stress are investigated. Sampling of the plant at f
Externí odkaz:
https://doaj.org/article/f16b769080514fb2acf2c6468e5538ef